热门资讯> 正文
Applied Therapeutics GAAP每股收益为-0.15美元，击败0.01美元
2025-08-14 15:38
- Applied Therapeutics(APLT) 0
- Cambria Global Asset Allocation ETF(GAA) 0
- WisdomTree Earnings 500 Fund(EPS) 0
- Applied Therapeutics press release (NASDAQ:APLT): Q2 GAAP EPS of -$0.15 beats by $0.01.
- Cash and cash equivalents totaled $30.4 million as of June 30, 2025, compared with $79.4 million at December 31, 2024.
More on Applied Therapeutics
- Seeking Alpha’s Quant Rating on Applied Therapeutics
- Historical earnings data for Applied Therapeutics
- Financial information for Applied Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
